A Preview Of ADC Therapeutics's Earnings
Portfolio Pulse from Benzinga Insights
ADC Therapeutics (NYSE:ADCT) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $-0.44. The company's past performance shows a pattern of beating EPS estimates, which has led to share price increases. However, the stock has been on a downward trend, with shares down 82.09% over the last 52-week period.
August 07, 2023 | 8:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
ADC Therapeutics is expected to report an EPS of $-0.44. Despite past EPS beats, the stock has been on a downward trend, with shares down 82.09% over the last 52-week period.
The company's earnings report is a key event that could impact its stock price. Given the estimated negative EPS and the stock's recent downward trend, it's likely that the stock price may continue to decline in the short term, unless the company provides positive guidance for the next quarter.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100